Sökning: "Neonatal vaccine"

Visar resultat 1 - 5 av 13 avhandlingar innehållade orden Neonatal vaccine.

1. 1. PROTEIN VACCINE AGAINST NEONATAL GROUP B STREPTOCOCCAL INFECTION Immunization experiments in animals and a serological study in humans

   Författare :Charlotte U Larsson; Avdelningen för medicinsk mikrobiologi; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; bakteriologi; mycology; bacteriology; Microbiology; virologi; mykologi; neonatal infection; human antibody; intranasal; vaccine; cholera toxin B subunit; Rib; α; Group B streptococcus; surface protein; Mikrobiologi; virology;

   Sammanfattning : Infection with group B streptococcus (GBS), an encapsulated bacterium, is an important cause of neonatal morbidity and mortality. Capsular polysaccharides and cell surface proteins of GBS are candidate antigens for development of a human GBS vaccine. Proteins have many advantages as vaccine antigens. LÄS MER

3. 2. Broadly protective nanoparticle-based mucosal vaccine against influenza virus infection

   Författare :Valentina Bernasconi; Göteborgs universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Mucosal vaccination; Influenza A virus; CTA1-DD; Nanoparticle; Targeted adjuvant; Nasal immunization; Oral immunization; Neonatal vaccine; Universal vaccine;

   Sammanfattning : Influenza is one of the major viral diseases affecting humans and it is responsible for three to five million cases of severe illness and about 250.000 to 500.000 deaths each year worldwide. LÄS MER

4. 3. Group B streptococci and other neonatal infections

   Författare :Elisabet Persson; Göteborgs universitet; []
   Nyckelord :Neonatal infections; sepsis; incidence; ; Group B streptococcus; ; serotype; ; epidemiology; ; genotype; ; surface protein; ; antibiotic susceptibility;

   Sammanfattning : The main objectives of this thesis were to estimate the incidence and etiology of invasive infections in neonates and to characterize invasive strains of group B streptococci from a defined geographic area. All infants aged 0-120 days with a bacterial or fungal isolate from blood or CSF in the defined area were identified. LÄS MER

5. 4. Seroepidemiology of vaccine-preventable and emerging RNA viruses in Rwanda

   Författare :Eric Seruyange; Göteborgs universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Seroprevalence; measles virus; rubella virus; Zika virus; West Nile virus; chikungunya virus; tick-borne encephalitis virus; mosquitoes; linear epitopes; Rwanda; Sweden;

   Sammanfattning : Abstract Infectious diseases are a leading cause of death in sub-Saharan Africa, and in Rwanda diarrhea, lower respiratory and other common infections are linked to high mortality and morbidity. For children ... LÄS MER

7. 5. Mechanisms for pneumococcal meningitis and a new vaccine platform to raise a serotype-independent protection in the host

   Författare :Sigrun Thorsdottir; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :;

   Sammanfattning : Streptococcus pneumoniae is a highly relevant pathogenic bacterium, responsible for a large fraction of deaths and disease morbidity in the world. The pneumococcus remains the leading cause of life-threatening pneumonia, septicemia and meningitis beyond neonatal age, despite global implementation of vaccination programs. LÄS MER